Twin Study Reveals Link Between Accelerated Biological Aging and Cognitive Decline
A new study using epigenetic clocks in identical twins reveals that faster biological aging is linked to increased memory decline, especially among those from lower socioeconomic backgrounds. These findings highlight the complex interplay between genetics, environment, and brain health.
Recent research conducted by psychologists at the University of Virginia has shed light on the connection between biological aging and memory deterioration. Utilizing advanced "epigenetic clocks"—scientific tools that estimate an individual's biological age—researchers have demonstrated that these measures can effectively predict cognitive decline in middle-aged adults. The study specifically focused on identical twins to control for genetic factors, offering a clearer view of how environmental and biological influences intertwine.
The findings, published in the journal Aging by doctoral student Sophie Bell and her advisor, Professor Eric Turkheimer, revealed that within pairs of genetically identical twins, the twin exhibiting faster biological aging also showed more significant memory and cognitive deficits by midlife. This suggests that epigenetic changes—modifications in gene expression that do not alter the underlying DNA sequence—play a critical role in brain aging.
A key aspect of the study involved examining socioeconomic status. The data indicated that twins raised in environments with lower socioeconomic conditions experienced a stronger correlation between accelerated epigenetic aging and cognitive decline. This highlights the influential role of socioeconomic factors on health and aging.
Bell explained that epigenetic clocks such as GrimAge and PhenoAge are reliable markers of biological aging and can serve as predictors for cognitive deterioration. Her work also emphasizes how early-life socioeconomic disadvantages may predispose individuals to faster aging and brain decline later in life.
The research leverages decades of data from the Louisville Twin Study, which has tracked twins from childhood through midlife since 1957. The study underscores the importance of twin research as a method for isolating genetic versus environmental influences on health.
Furthermore, Bell’s ongoing clinical work with dementia patients at UVA’s Memory and Aging Care Clinic complements her research. She plans to investigate blood-based biomarkers for Alzheimer’s disease among middle-aged twins to further understand their relationship with epigenetic aging and cognitive decline.
These insights contribute to a broader understanding of how biological and environmental factors impact aging, emphasizing the need for early intervention strategies, especially for vulnerable populations affected by socioeconomic disadvantages.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Half of Youth-Focused Clinicians Routinely Screen for Substance Use Disorders During Well Visits
Most youth-serving clinicians regularly screen adolescents for substance use disorders during well visits, but rates vary widely. Enhancing screening practices can improve early detection and treatment for adolescents at risk.
Concerns Rise as Vaccine Experts Criticized by U.S. Health Leadership
Vaccine experts who were recently dismissed by the U.S. Department of Health and Human Services warn that recent leadership changes threaten decades of immunization progress and public health safety.
Novo Nordisk Acquires US BioTech Leader Akero for $4.7 Billion to Advance Metabolic Disease Treatments
Novo Nordisk has acquired US biotech firm Akero Therapeutics for $4.7 billion, aiming to develop groundbreaking treatments for metabolic diseases like fatty liver and obesity. The deal emphasizes innovation in managing liver damage and expanding therapies for millions worldwide.
Innovative Technique Enables Long-Term Brain Activity Monitoring in Freely Moving Mice
A novel method, CaliAli, enables researchers to monitor neuronal activity in freely moving mice continuously for over 99 days, advancing long-term brain research and understanding of neurological disorders.